Continue to Read:Formulation Changes and Bridging During Formulation Development – Part 2
Prologue
Given the volume of new drugs being developed for launch as well as the effort being put into Life Cycle Management of drugs, “Formulation changes and Bridging studies during Formulation Development” is a key topic in demand and hence, I am choosing to write a two series article on this topic.
The first article provides an outline of formulations change during development, details of the kind of Formulation changes from Phase 1 clinical study to commercialization of drug, Formulation changes Post-Approval and Commercialization, types of Bridging Studies, their purpose, different types of bridging studies, considerations for bridging studies, study design and analysis of bridging studies,
The second article in the series would focus on the real-life examples of bridging studies due to formulation changes from Phase 1 clinical study to commercialization of drug and real-life examples of bridging studies due to Reformulation (formulation changes) post commercialization of drug.
Formulation Changes
Formulation changes are a critical and often inevitable part of drug development. They are made to optimize the drug product's safety, efficacy, stability, manufacturability, patient compliance, or regulatory needs. Changes could made to the drug's composition, manufacturing process, or both.
1. Optimization of Drug Efficacy and Stability
Bioavailability: Initial formulations might be adjusted to improve the drug's absorption and bioavailability (the degree to which the drug reaches circulation and its target in the body). Changes like adjusting particle size or using different excipients (inactive ingredients) can make a significant difference.
Stability: A stable formulation is crucial to ensure the drug remains effective over time. Adjustments might be needed if the drug degrades under certain conditions (e.g., temperature, light, moisture) or if interactions occur between the drug and excipients.
2. Enhancing Safety and Reducing Side Effects
Tolerability: If early testing reveals side effects, changes may be made to modify release rates, reduce peaks in drug levels, or alter absorption.
Inactive Ingredients: Sometimes certain excipients may cause allergic reactions or other adverse effects, leading to the substitution or removal of specific ingredients to enhance tolerability and safety.
3. Improving Patient Compliance and Convenience
Dosing and Administration: Formulation modifications are often made to simplify the dosing regimen or create easier methods of administration (e.g., shifting from injections to oral tablets or patches), making it more convenient and improving adherence.
Taste and Palatability: For oral or liquid formulations, especially those intended for children, taste can be a factor that requires changes. Flavoring agents or coatings may be added to improve the experience for patients.
4. Regulatory and Manufacturing Considerations
Scale-Up Feasibility: Formulations in early stages may work well in small lab-scale batches but not on an industrial scale. Adjustments are often needed to ensure the formulation can be consistently manufactured with quality control.
Regulatory Compliance: Regulatory agencies may set specific guidelines on ingredient types and levels, and formulations may need to be altered to meet these sta...
(All Rights Reserved)